Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus
Authors:
- Lydia Zorn-PaulyLZLydia Zorn-Pauly
- Anne Sae Lim von StuckradASAnne Sae Lim von Stuckrad
- Jens KlotscheJKJens Klotsche
- Thomas RoseTRThomas Rose
- Tilmann KallinichTKTilmann Kallinich
- Philipp EnghardPEPhilipp Enghard
- Lennard OstendorfLOLennard Ostendorf
- Marie BurnsMBMarie Burns
- Thomas DoernerTDThomas Doerner
- Christian MeiselCMChristian Meisel
- Udo SchneiderUSUdo Schneider
Preprint
Abstract
Objectives: To evaluate and compare the diagnostic accuracy of SIGLEC1, a surrogate marker of type I IFN, with established biomarkers in an inception cohort of systemic lupus erythematosus (SLE). Methods: SIGLEC1 was analysed by flow cytometry in 232 patients referred to our institution with suspected SLE between October 2015 and September 2020. Results: SLE was confirmed in 76 of 232 patients (32.8%) according to the 2019 EULAR/ACR classification criteria and their SIGLEC1 values were significantly higher compared to patients without SLE (p 99.9 % and 0.1 %, respectively. Using ROC analysis and Delong testing, the area under the curve (AUC) for SIGLEC1 (AUC=0.95) was significantly higher than for ANA (AUC=0.88, p=0.031), C3 (AUC=0.83, p=0.001) and C4 (AUC=0.83, p=0.002) but not for anti-dsDNA antibodies (AUC=0.90, p=0.163). Conclusion: IFN-I pathway activation is detectable in almost all newly diagnosed SLE patients. Thus, a negative test result for SIGLEC1 is powerful to exclude SLE in suspected cases.Keywords
All Related Versions
- Published version: Rheumatology, 61 (8), 3396.
This publication has 18 references indexed in Scilit:
- Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark studyRheumatology, 2017
- Interferon-stimulated gene 15 expression in systemic lupus erythematosusZeitschrift für Rheumatologie, 2017
- SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndromeRMD Open, 2016
- Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosusClinical Rheumatology, 2014
- HIV-1 Capture and Transmission by Dendritic Cells: The Role of Viral Glycolipids and the Cellular Receptor Siglec-1PLOS Pathogens, 2014
- IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2013
- Sialic acid–binding Ig‐like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosusArthritis & Rheumatism, 2008
- Prevalence of Physician-Diagnosed Systemic Lupus Erythematosus in the United States: Results from the Third National Health and Nutrition Examination SurveyJournal of Women's Health, 2004
- Role of Thrombocytosis in Diagnosis of Giant Cell Arteritis and Differentiation of arteritic from Non-Arteritic Anterior Ischemic Optic NeuropathyEuropean Journal of Ophthalmology, 2004
- Users' Guides to the Medical LiteratureJAMA, 1994